DGX Quest Diagnostics Incorporated
Stock · NYSE · United States · Healthcare · US74834L1008
NowoTrade is an independent information site. It is not affiliated with, endorsed by or sponsored by Quest Diagnostics Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price
255.63 USD
+0.35%
52-week range
171.18 – 259.00
Dividend yield1.35%
Market cap28.2B
NowoTrade score
63 Grade A
Price history
Daily prices in USD.
Updated 07 Nov 2026 09:31. Information, not advice.
Results
Next results
09 Feb 2027
in 94 days · 08:00 · estimate 2.68
Last results
3.00 vs 2.87 estimated
22 Oct 2026 · Beat +4.4%
Beat the estimate
11 of 12
0 missed · 1 in line · 9 beats in a row
Average surprise
+4.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Feb 2027 08:00 | 2.68 | — | — | Upcoming |
| 22 Oct 2026 06:00 | 2.87 | 3.00 | +4.4% | Beat |
| 23 Jul 2026 06:00 | 2.82 | 3.12 | +10.5% | Beat |
| 21 Apr 2026 06:00 | 2.37 | 2.50 | +5.6% | Beat |
| 10 Feb 2026 06:00 | 2.36 | 2.42 | +2.6% | Beat |
| 21 Oct 2025 06:00 | 2.50 | 2.60 | +3.9% | Beat |
| 22 Jul 2025 06:00 | 2.57 | 2.62 | +1.9% | Beat |
| 22 Apr 2025 06:00 | 2.15 | 2.21 | +2.8% | Beat |
| 30 Jan 2025 06:00 | 2.18 | 2.23 | +2.1% | Beat |
| 22 Oct 2024 06:00 | 2.26 | 2.30 | +1.9% | Beat |
| 23 Jul 2024 06:00 | 2.33 | 2.35 | +0.7% | In line |
| 23 Apr 2024 06:00 | 1.86 | 2.04 | +9.8% | Beat |
| 01 Feb 2024 06:00 | 2.11 | 2.15 | +1.7% | Beat |
| 24 Oct 2023 06:00 | 2.19 | 2.22 | +1.4% | Beat |
| 26 Jul 2023 06:00 | 2.26 | 2.30 | +1.9% | Beat |
| 27 Apr 2023 06:00 | 1.97 | 2.04 | +3.5% | Beat |
| 02 Feb 2023 06:00 | 1.90 | 1.98 | +4.0% | Beat |
| 20 Oct 2022 06:00 | 2.19 | 2.36 | +7.6% | Beat |
| 21 Jul 2022 06:00 | 2.27 | 2.36 | +3.9% | Beat |
| 21 Apr 2022 06:00 | 3.00 | 3.22 | +7.3% | Beat |
| 03 Feb 2022 06:00 | 3.21 | 3.33 | +3.8% | Beat |
| 21 Oct 2021 06:00 | 3.06 | 3.96 | +29.2% | Beat |
| 22 Jul 2021 06:00 | 2.86 | 3.18 | +11.1% | Beat |
| 22 Apr 2021 06:00 | 3.73 | 3.76 | +0.7% | In line |
| 04 Feb 2021 06:00 | 4.24 | 4.48 | +5.7% | Beat |
| 22 Oct 2020 06:00 | 3.73 | 4.31 | +15.6% | Beat |
| 23 Jul 2020 06:00 | 1.25 | 1.42 | +13.5% | Beat |
| 22 Apr 2020 07:00 | 0.88 | 0.94 | +6.7% | Beat |
| 30 Jan 2020 06:00 | 1.60 | 1.67 | +4.2% | Beat |
| 22 Oct 2019 06:00 | 1.71 | 1.76 | +2.9% | Beat |
| 23 Jul 2019 06:00 | 1.68 | 1.73 | +2.8% | Beat |
| 23 Apr 2019 06:00 | 1.38 | 1.40 | +1.7% | Beat |
| 14 Feb 2019 06:00 | 1.37 | 1.36 | -0.6% | In line |
| 23 Oct 2018 06:00 | 1.68 | 1.68 | +0.2% | In line |
| 24 Jul 2018 06:00 | 1.76 | 1.75 | -0.3% | In line |
| 19 Apr 2018 06:00 | 1.50 | 1.52 | +1.2% | Beat |
| 01 Feb 2018 06:00 | 1.37 | 1.40 | +1.9% | Beat |
| 19 Oct 2017 06:00 | 1.36 | 1.39 | +2.6% | Beat |
| 25 Jul 2017 06:00 | 1.42 | 1.55 | +9.5% | Beat |
| 20 Apr 2017 06:00 | 1.18 | 1.33 | +13.2% | Beat |
| 26 Jan 2017 06:00 | 1.27 | 1.31 | +3.0% | Beat |
| 20 Oct 2016 06:00 | 1.35 | 1.37 | +1.3% | Beat |
| 21 Jul 2016 06:00 | 1.32 | 1.34 | +1.8% | Beat |
| 21 Apr 2016 06:00 | 1.12 | 1.12 | +0.1% | In line |
| 28 Jan 2016 06:00 | 1.19 | 1.19 | +0.1% | In line |
| 22 Oct 2015 06:00 | 1.26 | 1.28 | +1.6% | Beat |
| 23 Jul 2015 07:00 | 1.23 | 1.25 | +1.2% | Beat |
| 23 Apr 2015 07:00 | 1.04 | 1.05 | +0.8% | In line |
| 29 Jan 2015 07:00 | 1.05 | 1.08 | +3.2% | Beat |
| 23 Oct 2014 07:00 | 1.08 | 1.10 | +2.3% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 11B | +11.8% | 992M | 9.0% | 8.75 | +13.8% | 1.4B |
| 2024 | 9.9B | +6.7% | 871M | 8.8% | 7.69 | +2.7% | 909M |
| 2023 | 9.3B | -6.4% | 854M | 9.2% | 7.49 | -6.0% | 864M |
| 2022 | 9.9B | — | 946M | 9.6% | 7.97 | — | 1.3B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 06 Nov 2026 | 251.64 | 258.13 | 250.00 | 255.63 | +0.35% | 945,200 | |
| 05 Nov 2026 | 258.74 | 259.00 | 251.23 | 254.74 | -0.37% | 969,100 | |
| 04 Nov 2026 | 250.61 | 255.81 | 247.39 | 255.68 | +3.49% | 915,900 | |
| 03 Nov 2026 | 252.64 | 252.64 | 244.58 | 247.06 | -1.50% | 1,064,500 | |
| 02 Nov 2026 | 251.60 | 251.98 | 247.71 | 250.81 | -0.40% | 996,300 | |
| 30 Oct 2026 | 255.14 | 256.99 | 250.95 | 251.82 | -0.43% | 919,600 | |
| 29 Oct 2026 | 246.25 | 253.12 | 245.40 | 252.92 | +2.97% | 945,900 | |
| 28 Oct 2026 | 242.96 | 249.73 | 242.34 | 245.62 | +1.26% | 932,700 | |
| 27 Oct 2026 | 241.96 | 243.27 | 239.59 | 242.56 | -0.16% | 919,000 | |
| 26 Oct 2026 | 243.00 | 244.22 | 240.98 | 242.95 | +0.44% | 959,600 | |
| 23 Oct 2026 | 239.63 | 244.33 | 239.63 | 241.89 | -0.57% | 933,400 | |
| 22 Oct 2026 | 226.50 | 246.00 | 226.22 | 243.28 | +1.82% | 1,686,000 | |
| 21 Oct 2026 | 235.34 | 240.56 | 223.50 | 238.93 | +0.76% | 1,205,100 | |
| 20 Oct 2026 | 236.00 | 237.29 | 234.06 | 237.12 | +0.94% | 1,103,700 | |
| 19 Oct 2026 | 234.40 | 235.99 | 233.82 | 234.91 | -0.04% | 864,600 | |
| 16 Oct 2026 | 239.67 | 240.75 | 233.56 | 235.00 | -1.74% | 799,600 | |
| 15 Oct 2026 | 235.85 | 239.17 | 235.57 | 239.15 | +2.45% | 1,002,700 | |
| 14 Oct 2026 | 231.32 | 234.97 | 231.32 | 233.43 | +1.29% | 1,201,400 | |
| 13 Oct 2026 | 233.13 | 234.33 | 230.23 | 230.46 | -0.93% | 1,010,100 | |
| 12 Oct 2026 | 228.66 | 234.64 | 228.66 | 232.63 | +0.72% | 865,200 | |
| 09 Oct 2026 | 227.86 | 232.18 | 227.86 | 230.97 | +0.07% | 775,400 | |
| 08 Oct 2026 | 228.16 | 231.08 | 226.36 | 230.81 | +1.65% | 941,900 | |
| 07 Oct 2026 | 228.51 | 229.80 | 226.81 | 227.06 | -0.58% | 927,400 | |
| 06 Oct 2026 | 229.92 | 232.09 | 225.78 | 228.39 | -1.65% | 1,783,900 | 0.8600 |
| 05 Oct 2026 | 232.93 | 233.65 | 229.96 | 232.22 | -0.48% | 1,014,100 |
Page 1 of 51
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- IBD Stock Of The Day Quest Diagnostics Is Bucking The Medtech Malaise (opens in a new tab) Investor's Business Daily · 06 Nov 2026 21:57
- EBay Leads Five Stocks Near Buy Points From Resilient Sectors (opens in a new tab) Investor's Business Daily · 31 Oct 2026 12:00
- Labcorp, Quest urge RESULTS Act passage as lab payment cuts loom (opens in a new tab) MedTech Dive · 30 Oct 2026 14:47
- Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings (opens in a new tab) Simply Wall St. · 24 Oct 2026 04:14
- Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening (opens in a new tab) Simply Wall St. · 24 Oct 2026 00:12
- Quest Diagnostics (DGX) Stock Could Be Undervalued Despite Raised Full Year Guidance (opens in a new tab) Simply Wall St. · 23 Oct 2026 18:15
- Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach (opens in a new tab) TechCrunch · 23 Oct 2026 16:00
- Was Quest's 'Good Enough' Third Quarter Actually Good Enough? (opens in a new tab) Investor's Business Daily · 22 Oct 2026 21:21
- Quest Diagnostics: 3 Key Takeaways for Long-Term Investors (opens in a new tab) Motley Fool · 22 Oct 2026 19:24
- What Quest Diagnostics (DGX) Said on Its Q3 Earnings Call (opens in a new tab) MarketBeat · 22 Oct 2026 19:04
- Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript (opens in a new tab) Motley Fool · 22 Oct 2026 18:59
- Quest Diagnostics Incorporated Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 22 Oct 2026 18:34
- DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market (opens in a new tab) Zacks · 22 Oct 2026 18:17
- Laboratory operator Quest reports cyber breach affecting patient records (opens in a new tab) Reuters · 22 Oct 2026 12:40
- Quest’s (NYSE:DGX) Q3 2026: beats on revenue (opens in a new tab) StockStory · 22 Oct 2026 12:07
Headlines link to the original articles of the publishers shown; NowoTrade does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 254.74 USD
- Market cap
- 28.2B
- Dividend yield
- 1.35%
- 5-year average yield
- 1.81%
- Payout ratio
- 25%
- Last dividend
- 0.8600 USD · 06 Oct 2026
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 06 Oct 2026 | 0.8600 USD |
| 08 Jul 2026 | 0.8600 USD |
| 06 Apr 2026 | 0.8600 USD |
| 13 Jan 2026 | 0.8000 USD |
| 03 Oct 2025 | 0.8000 USD |
| 07 Jul 2025 | 0.8000 USD |
| 07 Apr 2025 | 0.8000 USD |
| 14 Jan 2025 | 0.7500 USD |
| 04 Oct 2024 | 0.7500 USD |
| 08 Jul 2024 | 0.7500 USD |
| 05 Apr 2024 | 0.7500 USD |
| 16 Jan 2024 | 0.7100 USD |
Why this score
| Part of the score | Points | Why |
|---|---|---|
| Yield Dividends per year as a share of today's price. Very high yields count for less: they often signal trouble. | 5.6 / 25 |
|
| Dividend safety Can the company keep paying? The dividend against free cash flow and earnings, plus debt and interest cover. | 21.1 / 25 |
|
| Dividend growth How many years in a row the dividend has risen, and how fast. | 15.0 / 15 |
|
| Quality Return on equity, net margin and how stable the margins are. | 11.2 / 15 |
|
| Valuation Free cash flow yield and the P/E against its sector. | 6.9 / 10 |
|
| Analysts How far the analysts' average target is from today's price. | 1.8 / 5 |
|
Income profile: it pays a dividend, so it is scored mainly on the dividend and how safe it is. Based on 95% of the figures (grade A).
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Figures
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| P/E (trailing) | 25.46× | Weak | 31.09× |
| P/E (forward) | 21.34× | Fair | 14.98× |
| Price / book | 3.68× | Weak | 3.94× |
| Price / sales | 2.38× | Fair | 3.37× |
| EV / EBITDA | 14.47× | Fair | 12.96× |
| Free cash flow yield | 3.1% | Fair | 2.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Gross margin | 33.2% | Fair | 59.2% |
| Operating margin | 15.6% | Good | 7.4% |
| Net margin | 9.5% | Fair | 3.4% |
| Return on equity | 15.3% | Good | 5.7% |
| Return on assets | 6.6% | Fair | 3.6% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Revenue growth / year | 3.7% | Fair | 10.8% |
| EPS growth / year | 3.2% | Fair | 10.2% |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Debt / equity | 0.8× | Good | 0.46× |
| Net debt / EBITDA | 2.38× | Fair | 1.5× |
| Interest cover | 5.62× | Fair | 3.26× |
| Current ratio | 1.7× | Good | 2.35× |
| Figure | Value | Reading | Sector median |
|---|---|---|---|
| Payout of earnings | 25.1% | Good | 0% |
| Payout of free cash flow | 40.5% | Good | 30.1% |
| Payout of free cash flow (3 years) | 31.9% | Good | — |
| Dividend growth / year | 12.5% | Good | 7.1% |
| Years of rising dividends | 13 | Good | 2 |
The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.
Follow DGX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.